Ventricular Arrhythmia Treatment Agent ( Bumac Cab. ), New ACE Inhibitor ( Alphrin Tab. ), Alpha1 - Adrenergic Receptor Selective Blocking Agent ( Minecin Tab. ), Anti - Hypertensive Agent ( Anprasol Inj. ), Migraine Attack & Vertigo Therapeutic Agent ( Headache Cap. )
Product ID: P07

Specifications:

• Ventricular arrhythmia treatment agent (bumac cab.):
• 1 Cab.
• Mexiletine.HCI: 100mg
• 500Cab.
• 226/C
• New ACE inhibitor (alphrin Tab.):
• 1 Tab.
• Enalapri maleate: 10mg
• 100Tab.; 500Tab.
• 728/T
• Alpha1-adrenergic receptor selective blocking agent (minecin Tab.):
• 1 Tab.
• Prazocin.HCI: 1mg
• 500Tab.
• 44/T
• Anti-hypertensive agent (anprasol inj.):
• 1Amp. (1ml)
• Hydralazine.HCI: 20mg
• 1ml x 10Amp.
• 1,608/A
• Migraine attack & vertigo therapeutic agent (headache cap.)
• 1 Cap.
• Flnarizine.HCI: 5.9mg
• 300Cap.
• 384/C

Features:

• Ventricular arrhythmia treatment agent (bumac cab.): Na-channel blacker inhibition of permture ventricular contraction and ventricular ectopy.
• New ACE inhibitor (alphrin Tab.): Hypertension, cardiac failure.
• Alpha1-adrenergic receptor selective blocking agent (minecin Tab.): Hypertension, congestive heart failure, ect.
• Anti-hypertensive agent (anprasol inj.): Hypertensive crises.
• Migraine attack & vertigo therapeutic agent (headache cap.): Intractable migraine, vestibular vertigo.





Ordering information:

• Minimum Order: Negotiable set